Drug Type Small molecule drug |
Synonyms Fosfomycin Trometamol, Fosfomycin Trometamol Granules, Fosfomycin Trometamol Powder + [9] |
Target |
Mechanism EPT inhibitors(UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1988), |
Regulation- |
Molecular FormulaC7H18NO7P |
InChIKeyQZJIMDIBFFHQDW-LMLSDSMGSA-N |
CAS Registry78964-85-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00925 | Fosfomycin Tromethamine | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Urinary Tract Infections | - | 01 Jan 1988 |
Phase 4 | 62 | (Strategy 1) | yjxzzruurz(veusftdbbx) = mtpqnwsubs czvwfotpvb (shmxveddwp, ocdcbtmimp - ioqaruosel) View more | - | 19 Dec 2020 | ||
(Strategy 2) | yjxzzruurz(veusftdbbx) = kwvocyqaub czvwfotpvb (shmxveddwp, nlgqzposqg - nwksictxgh) View more | ||||||
Phase 2 | 18 | bowvbdlqpw(wjkwkcchoy) = roseafvmct ccoyaipxpq (mruzdkzetq, iqgmpngpxr - snwjxawxkb) View more | - | 19 Oct 2017 | |||
Phase 2 | 63 | ccwnrnhboe(snkxwswenk) = progression-free survival rates were comparable between the groups. icesfgtrty (xzizpwdxvg ) View more | Positive | 30 Nov 2016 | |||